Drug · DIN 02530589
SUSVIMO
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since September 14, 2022.
- Drug Identification Number (DIN)
- 02530589
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Ranibizumab S01LA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANIBIZUMAB | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 14, 2022: NOC 28961New Drug Submission (NDS)